Jounce Therapeutics, Inc. EBITDA Margin 2017-2022 | JNCE
Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for Jounce Therapeutics, Inc. (JNCE) over the last 10 years. The current EBITDA margin for Jounce Therapeutics, Inc. as of December 31, 2022 is .
| EBITDA Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM EBITDA | EBITDA Margin |
| 2021-12-31 | $0.03B | $-0.09B | -322.22% |
| 2019-12-31 | $0.15B | $0.06B | 37.41% |
| 2019-09-30 | $0.17B | $0.08B | 44.91% |
| 2019-06-30 | $0.06B | $-0.03B | -49.21% |
| 2019-03-31 | $0.07B | $-0.03B | -44.62% |
| 2018-12-31 | $0.07B | $-0.03B | -44.62% |
| 2018-09-30 | $0.06B | $-0.04B | -62.07% |
| 2018-06-30 | $0.06B | $-0.03B | -50.82% |
| 2018-03-31 | $0.06B | $-0.03B | -43.55% |
| 2017-12-31 | $0.07B | $-0.01B | -18.31% |
| 2017-09-30 | $0.08B | $0.00B | 3.85% |
| 2017-06-30 | $0.08B | $0.01B | 12.99% |
